7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		                 
      cash flows from operating activities:
    		                 
      net income
    		-11,597,000 -26,437,000 -15,076,000 -9,896,000 -10,199,000 -13,704,000 -16,604,000 -10,553,000 -12,010,000 -26,559,000 -18,343,000 -24,424,000 -15,041,000 -16,549,000 -19,995,000 -23,905,000 -14,711,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                 
      depreciation and amortization
    		5,000,000 4,495,000 4,246,000 3,390,000 3,213,000 3,256,000 3,153,000 2,799,000 2,478,000 2,895,000 2,566,000 2,103,000 1,909,000 2,008,000 1,799,000 1,292,000 817,000 
      impairment of assets
    		       0 151,000 219,000 27,000 380,000      
      reduction in carrying amount of right-of-use asset
    		1,138,000 1,112,000 1,100,000 1,130,000 1,126,000 1,106,000 1,096,000 1,098,000 1,078,000 10,244,000 1,935,000 1,885,000 1,811,000 1,775,000 1,765,000 144,000 369,000 
      lease termination
    		16,000 0 -30,000               
      stock-based compensation
    		10,748,000 7,895,000 7,342,000               
      revaluation of contingent consideration
    		   0 0 0 137,000 266,000 118,000   383,000 0 0 434,000   
      income from unconsolidated joint venture
    		-54,000 0 -90,000  -51,000 55,000 -97,000  66,000 -137,000 -66,000  3,000 -69,000 -34,000   
      donation of common stock
    		950,000 614,000 516,000 623,000 406,000 314,000 343,000 333,000 326,000 0 370,000 0 987,000   1,069,000  
      loss on debt extinguishment
    		0               0  
      gain on sale of property and equipment
    		                 
      amortization of deferred costs on convertible notes
    		590,000 472,000 465,000 465,000 464,000 466,000 464,000 464,000 466,000 464,000 466,000 468,000 469,000 469,000 312,000   
      deferred tax benefit
    		-21,000                 
      changes in other assets and liabilities:
    		                 
      accounts receivable
    		-9,865,000 -147,000 -13,358,000 2,514,000 -6,970,000 -1,825,000 532,000 -5,721,000 -6,565,000 -5,504,000 -2,804,000 2,109,000 -7,199,000 -5,688,000 -6,145,000 -472,000 -3,771,000 
      inventory
    		380,000 -531,000 -41,000 -684,000 -565,000 7,000 -40,000 -1,533,000 -22,000 -128,000 133,000 4,031,000 -3,952,000 452,000 -180,000 -549,000 64,000 
      prepaid expenses
    		-786,000 1,401,000 -1,519,000 -187,000 1,281,000 -62,000 -433,000 -666,000 918,000 1,232,000 185,000 168,000 -135,000 -2,216,000 567,000 55,000 1,190,000 
      other assets
    		-1,174,000 1,936,000 -1,995,000 -141,000 1,761,000 3,035,000 -442,000 -1,475,000 3,941,000 1,141,000 -3,687,000 -3,094,000 -61,000 -3,499,000 -362,000 -263,000 80,000 
      accounts payable and accrued cost of revenue
    		4,367,000 -8,687,000 15,048,000               
      other accrued expenses
    		7,106,000 2,534,000 -540,000               
      contract liabilities
    		1,120,000 173,000 1,877,000 -235,000 -803,000 -558,000 2,277,000 -2,582,000 -292,000 34,000 1,436,000 -2,262,000 -85,000 717,000 2,145,000 -2,678,000 -862,000 
      lease liabilities
    		-2,032,000 -1,639,000 -1,531,000 -1,843,000 -1,697,000 -1,700,000 -1,671,000 -1,675,000 -1,476,000 -1,399,000 -970,000 -1,508,000 -1,446,000 -1,404,000 -1,369,000 72,000 -383,000 
      other liabilities
    		-2,000 -9,000 -13,000 -2,000              
      income taxes payable
    		-141,000 -16,000 -92,000 115,000 -466,000 -878,000 -276,000 -472,000   157,000       
      net cash from operating activities
    		5,792,000 -427,000 -3,691,000 9,085,000 -3,634,000 -9,101,000 -11,734,000 -1,294,000 -5,976,000 -6,152,000 -16,455,000 -17,065,000 -11,314,000 -9,937,000 -24,259,000 -31,201,000 -16,810,000 
      capex
    		-7,436,000 -6,963,000 -5,499,000 -4,537,000 -4,810,000 -4,403,000 -4,347,000 -6,423,000 -3,571,000 -4,306,000 -4,108,000 -4,042,000 -4,172,000 -2,893,000 -2,543,000 -1,637,000 -1,746,000 
      free cash flows
    		-1,644,000 -7,390,000 -9,190,000 4,548,000 -8,444,000 -13,504,000 -16,081,000 -7,717,000 -9,547,000 -10,458,000 -20,563,000 -21,107,000 -15,486,000 -12,830,000 -26,802,000 -32,838,000 -18,556,000 
      cash flows from investing activities:
    		                 
      purchases of marketable securities
    		-2,133,000 -2,167,000 -2,271,000 -2,498,000 -2,772,000 -10,755,000 -2,726,000 -2,952,000 -2,989,000         
      proceeds from sale of marketable securities
    		7,500,000 9,000,000 4,000,000 1,500,000 5,000,000 0 10,000,000 20,000,000 0   58,923,000 0 0 4,000   
      purchases of property and equipment
    		-7,449,000 -6,963,000 -5,499,000 -4,537,000 -4,810,000 -4,403,000 -4,347,000 -6,423,000 -3,571,000 -4,306,000 -4,186,000 -4,042,000 -4,172,000 -2,893,000 -2,543,000 -1,637,000 -1,877,000 
      proceeds from sale of property and equipment
    		   0 0   0 0 0 223,000 24,000 0 0 165,000   
      net cash from investing activities
    		-2,148,000 -148,000 -3,686,000 -5,445,000 -2,594,000 -15,067,000 2,927,000 10,625,000 -6,560,000 22,741,000 -10,000,000 52,706,000 -5,510,000 -3,361,000 -282,465,000 58,855,000 -268,855,000 
      cash flows from financing activities:
    		                 
      proceeds from issuance of convertible notes
    		0           0 0 0 287,500,000   
      costs incurred in connection with issuance of convertible notes
    		-828,000           0 0 -8,000 -9,301,000   
      payments for repurchase of convertible notes
    		0                 
      purchase of capped calls
    		0                 
      purchase of treasury stock
    		0                 
      proceeds from stock options exercised
    		1,288,000 905,000 510,000 1,889,000 1,420,000 562,000 1,233,000 481,000 284,000 661,000 483,000 398,000 847,000 1,207,000 1,263,000 504,000 455,000 
      net cash from financing activities
    		460,000 1,536,000 510,000 1,424,000 1,420,000 562,000 1,233,000 -361,000 284,000 661,000 483,000 -534,000 847,000 1,199,000 279,460,000 858,000 306,108,000 
      effect of foreign currency translation on cash and cash equivalents
    		-10,000 283,000 142,000 -262,000 167,000 -24,000 -149,000 81,000 -113,000 -217,000 15,000 58,000 -359,000 -37,000 -29,000 -28,000 -16,000 
      net decrease in cash and cash equivalents
    		4,094,000 1,244,000 -6,725,000 4,802,000 -4,641,000 -23,630,000 -7,723,000  -12,365,000 17,033,000 -25,957,000  -16,336,000 -12,136,000 -27,293,000   
      cash and cash equivalents at beginning of the period
    		0 0 22,232,000  0 0 53,424,000      0 0 86,262,000   
      cash and cash equivalents at end of the period
    		4,094,000 1,244,000 15,507,000  -4,641,000 -23,630,000 45,701,000  -12,365,000 17,033,000 39,705,000  -16,336,000 -12,136,000 58,969,000   
      supplemental cash flow information:
    		                 
      cash paid for interest
    		429,000 733,000 1,438,000 0 1,437,000 0 1,438,000 0 1,437,000 0 1,438,000 0    0 248,000 
      non-cash investing and financing activities:
    		                 
      non-cash purchase of property and equipment
    		13,000          78,000      131,000 
      non-cash consideration in connection with business combination
    		0 0 625,000     0 0 0 1,593,000       
      distributions in excess of earnings
    		 -18,000 84,000               
      non-cash costs incurred in connection with the issuance of convertible notes
    		                 
      (income) income from unconsolidated joint venture
    		                 
      losses on marketable securities
    		                 
      loss on sale of property and equipment
    		       0 0 1,000 91,000 -24,000 0 0 71,000   
      inventory write-off
    		       0 0         
      restructuring charges
    		                 
      cash paid for business combination, net of cash acquired
    		       0 0 0 -3,349,000       
      payment of contingent consideration
    		                 
      payments on finance lease obligations
    		           0 0 0 -2,000 -3,000 -3,000 
      cash and cash equivalents at beginning of the year
    		       0 0 0 65,662,000       
      cash and cash equivalents at end of the year
    		                 
      stock based compensation
    		    6,954,000 8,125,000 6,036,000 5,896,000 5,730,000 5,798,000 4,694,000 5,124,000 5,113,000 5,479,000 3,456,000 2,648,000 2,267,000 
      (gain) loss on sale of property and equipment
    		    0             
      deferred taxes benefit
    		    -15,000   -88,000 -22,000 -21,000 -23,000 -651,000 0 0 -2,000   
      accounts payable
    		    -3,865,000 -3,779,000 -10,649,000 6,103,000 690,000 453,000 -503,000 25,000 -2,113,000 4,625,000 -2,752,000 5,615,000 -7,922,000 
      accrued expenses
    		    5,263,000 -2,921,000 4,440,000 6,421,000 -1,711,000 4,862,000 -2,119,000 -5,188,000 7,632,000 802,000 -2,843,000 -15,939,000 4,384,000 
      non-cash interest expense
    		               0 0 
      restructuring charge
    		                 
      proceeds from life insurance
    		                 
      proceeds from initial public offering, net of underwriters' discount
    		               0  
      payments in connection with initial public offering
    		               317,000 -3,471,000 
      repayment of term loan
    		               0  
      proceeds from the exercise of warrants
    		                 
      net increase in cash and cash equivalents
    		               28,484,000 20,427,000 
      shares issued in business combinations
    		                 
      non-cash income tax benefit
    		            0 0 -559,000   
      purchase of marketable securities
    		          -2,688,000 -2,199,000 -1,338,000 -468,000 -280,091,000 -489,000  
      loss (income) from unconsolidated joint venture
    		                 
      purchase of short-term investments
    		                 
      proceeds from short-term investments
    		                 
      cash paid for business combinations, net of cash acquired
    		                 
      proceeds from issuance of series a-2, series b, series c, series d and series e convertible preferred stock, net of issuance costs
    		                 
      repurchase of series a-2, series b, series c and series d convertible preferred stock
    		                 
      deemed dividend to preferred stockholders
    		                 
      proceeds from term loan
    		                 
      proceeds from other borrowings
    		                 
      repayment of other borrowings
    		                 
      non-cash consideration in connection with business combinations
    		                 
      unrealized loss on marketable securities
    		            469,000 332,000 858,000 1,763,000  
      non-cash investing activity:
    		                 
      impairment of long-lived assets
    		                 
      non-cash financing activity:
    		                 
      non-cash amounts incurred in connection with initial public offering
    		                 
      deferred commissions
    		              -1,425,000   
      impairment of goodwill and intangible assets
    		                 
      inventory write off
    		                 
      accretion of discount on short-term investments
    		                 
      payment on line of credit
    		                 
      cash and cash equivalents at beginning of period
    		                0 
      cash and cash equivalents at end of period
    		                20,427,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.